Live Quote · NASDAQMDGLHealthcare· Biotechnology

Madrigal Pharmaceuticals, Inc.

$379.10▼ 4.45%($-17.64)
MKT CAP $8.81BNEXT EARNINGS Feb 18, 2027
50%
Bullish
TickerSpark Score
62/100
▌ Mixed
60
Valuation
40
Profitability
100
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDGL research report →

Analyst Price Target
$669.22+76.5% vs. today

Range $533 – $962

Analyst RatingBuy
22 Buy2 Hold1 Sell

Price Chart

-30.07% · this period
$602.83$490.97$379.10Nov 20May 26Nov 20
52-Week Range10% of range
Low
$353.54
Current
$379.10
High
$615.00